December 9, 2013 Synthetic Biologics' Webcast Conference Call Set for 9:00 a.m. EST this Morning, December 9th
December 7, 2013 Synthetic Biologics Enters into License with Cedars-Sinai Medical Center to Develop Novel Anti-infective Approaches for Irritable Bowel Syndrome (IBS), Obesity and Diabetes
December 2, 2013 Synthetic Biologics to Present at the LD MICRO VI: Main Event Conference in Los Angeles
November 14, 2013 Synthetic Biologics' SYN-004 for the Prevention of C. difficile Infections Named a "Top Project to Watch" by Elsevier Business Intelligence
November 14, 2013 Synthetic Biologics Reports Third Quarter 2013 Financial Results and Operational Update
October 15, 2013 Synthetic Biologics Initiates Manufacturing of SYN-004 for Use in Preclinical and Clinical Trials to Target the Prevention of C. difficile Infections
September 10, 2013 Synthetic Biologics to Present at the First Global Life Sciences Conference in Warsaw, Poland
September 3, 2013 Synthetic Biologics to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City
